MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 EXPRESSION IN PEDIATRIC TUMOR-CELLS - EFFECTS OF TUMOR-CELL PROLIFERATION MODULATORS ON GELATINOLYTIC ACTIVITY

被引:18
|
作者
DEVEAS, RG
SCHWEIGERER, L
MEDINA, MA
机构
[1] UNIV MALAGA,FAC CIENCIAS,BIOQUIM & BIOL MOLEC LAB,E-29071 MALAGA,SPAIN
[2] CHILDRENS UNIV HOSP,DIV HEMATOL ONCOL,D-69120 HEIDELBERG,GERMANY
关键词
72-KDA GELATINASE; TYPE IV COLLAGENASE; MMP-2; TIMP-2; NEUROBLASTOMA; OSTEOSARCOMA; RHABDOMYOSARCOMA; GENISTEIN;
D O I
10.1007/BF01209593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have examined the expression of 72-kDa gelatinase/type IV collagenase or matrix metalloproteinase-2 (MMP-2) and its inhibitor, tissue inhibitor of metalloproteinase-2 (TIMP-2), in various cell lines derived from paediatric tumours. In a neuroblastoma model system of tumour progression, the expression level of MMP-2 mRNA was higher in the more malignant cell line. Surprisingly, MMP-2 was not expressed in the highly malignant rhabdomyosarcoma A-204 cell line. TIMP-2 showed higher expression levels in the 007 and U-2OS tumour cell lines than in the more malignant ones, WAC2 and A-204 cells. We have also determined the effect of some tumour cell proliferation modulators on gelatinolytic activity. While basic fibroblast growth factor and retinoic acid produced no apparent change in gelatinolytic activity, genistein induced in partial inhibition of gelatinolytic activity.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 50 条
  • [31] An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy
    Han, Sang Youb
    Jee, Yi Hwa
    Han, Kum Hyun
    Kang, Young Sun
    Kim, Hyoung Kyu
    Han, Jee Young
    Kim, Young Sik
    Cha, Dae Ryong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2406 - 2416
  • [32] Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate
    Thier, M
    Roeb, E
    Breuer, B
    Bayer, TA
    Halfter, H
    Weis, J
    CANCER LETTERS, 2000, 149 (1-2) : 163 - 170
  • [33] Erythropoietin Modulates Imbalance of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in Doxorubicin-induced Cardiotoxicity
    Chen, Xing
    Guo, Zhihua
    Wang, Peixian
    Xu, Miqing
    HEART LUNG AND CIRCULATION, 2014, 23 (08): : 772 - 777
  • [34] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver
    Liu, HL
    Li, XH
    Wang, DY
    Yang, SP
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (06) : 881 - 884
  • [35] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver
    Hai Lin Liu Xuan Hai Li Dan Yi Wang Shao Ping Yang Department of Gastroenterology and Hepatology
    World Journal of Gastroenterology, 2000, 6 (06) : 881 - 884
  • [36] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-2 in human endometrial carcinoma
    陈梅
    薄乃秀
    黄亚军
    戴琪
    巩丽梅
    生殖医学杂志, 2010, 19(S2) (S2) : 59 - 63
  • [37] Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
    Kurschat, P
    Zigrino, P
    Nischt, R
    Breitkopf, K
    Steurer, P
    Klein, CE
    Krieg, T
    Mauch, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) : 21056 - 21062
  • [38] The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers
    Mwaura, B
    Mahendran, B
    Hynes, N
    Defreitas, D
    Avalos, G
    Adegbola, T
    Adharn, M
    Connolly, CE
    Sultan, S
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2006, 31 (03) : 306 - 310
  • [39] Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors
    Sogawa, K
    Kondo, K
    Fujino, H
    Takahashi, Y
    Miyoshi, T
    Sakiyama, S
    Mukai, K
    Monden, Y
    CANCER, 2003, 98 (09) : 1822 - 1829
  • [40] Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis
    Theret, N
    Musso, O
    Campion, JP
    Turlin, B
    Loreal, O
    LHelgoualch, A
    Clement, B
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (04) : 426 - 432